CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5453-5460

  Chen, Yu ^a   DeWeese, Theodore ^b   Dilley, Jeanette ^a   Zhang, Yiwei ^a   Li, Yuanhao ^a   Ramesh, Nagarajan ^a   Lee, Jake ^a   Pennathur Das, Rukmini ^a   Radzyminski, John ^a   Wypych, Joseph ^a   Brignetti, Dominic ^a   Scott, Sara ^b   Stephens, Jennifer ^b   Karpf, David B ^a   Henderson, Daniel R ^a   Yu, De Chao ^a  

^a Calydon Inc   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CELL DEATH; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; MOUSE; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; VIRUS PARTICLE; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; CELL SURVIVAL; COMBINED MODALITY THERAPY; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035879042     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Follow-up of irradiated prostatic carcinoma by aspiration biopsy
2. External beam radiotherapy dose response of prostate cancer
3. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions
4. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients
5. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
6. External beam radiation therapy for prostate cancer
7. Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy
8. Treatment of local failure of prostate cancer after radiotherapy and surgery
9. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
10. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation
11. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31
12. Prostate-attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen positive prostate cancer cells
13. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of Calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy
14. The addition of the Ad5 Region E3 enables Calydon virus 787 to eliminate distant prostate tumor xenografts
15. Results of a Phase 1 study of CN706, a replication-competent cytolytic adenovirus, for the treatment of adenocarcinoma of the prostate which is locally recurrent following radiation therapy
16. Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel
17. In vivo radiosensitizing effect of the adenovirus E/A gene in murine and human malignant tumors
18. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
19. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines
20. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth
21. An in situ method for estimating cell survival in a solid tumor
22. The effect of tumor size on necrosis and polarographically measured pO2
23. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
24. Intratumoral angiogenesis: A new prognostic indicator for stage I endometrial adenocarcinomas?
25. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer
26. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
27. Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: Implications and proposals for human therapy
28. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase
29. An adenovirus type 5 early gene function regulates expression of other early viral genes
30. Adenovirus and their replication
31. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus Ela mutants
32. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus ElA gene
33. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus Ela gene
34. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
35. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy
36. Principles of cancer management: Chemotherapy